This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

James E. Burke, Former Chairman And CEO Of Johnson & Johnson, Dies At 87

Stocks in this article: JNJ

NEW BRUNSWICK, N.J., Oct. 1, 2012 /PRNewswire-FirstCall/ -- Former Johnson & Johnson (NYSE: JNJ) Chairman and Chief Executive Officer James E. Burke, whose extraordinary career in the private and public sectors earned him the prestigious Presidential Medal of Freedom, died late Friday at the age of 87.



" Jim Burke was among the greatest leaders in the history of American business," said Alex Gorsky, Chief Executive Officer of Johnson & Johnson. "His commitment to the values expressed in Our Credo served as the foundation for everything Jim did throughout his remarkable career. He will forever inspire the people of Johnson & Johnson."

"Jim was a courageous leader, who defined the very essence of corporate and civic responsibility," said William C. Weldon, Chairman of Johnson & Johnson. "His passion and commitment to children and families benefited not only Johnson & Johnson, but our country as well."

Born in Rutland, Vermont in 1925, Burke grew up in the small upstate New York town of Slingerlands. After commanding a landing craft tank in the Pacific during World War II as an ensign in the United States Navy, he completed his college education and was graduated from Holy Cross in 1947 and the Harvard Business School in 1949. In 1953, Burke joined Johnson & Johnson as a product director. There, he would spend 37 years of his life, 16 of them as president (1973-1976) and then chairman and chief executive officer (1976-1989).

During Burke's tenure as chairman and chief executive officer, Johnson & Johnson experienced noteworthy growth. The company's sales grew more than threefold to $9 billion; net income increased nearly fivefold; its market capitalization nearly tripled; and it expanded its presence from 37 to 54 countries, all while focusing on meeting significant unmet needs of patients and consumers around the world. While his accomplishments were significant and shaped Johnson & Johnson as a global, health care concern, Burke's career will likely be best remembered for his steady leadership of the company during the Tylenol poisonings in 1982 and 1986.

After retiring from Johnson & Johnson in 1989, Burke assumed the chairmanship of the Partnership for a Drug-Free America (now The Partnership at, a non-profit organization founded by the American Association of Advertising Agencies. The Partnership created hard-hitting advertising designed to change social attitudes about illicit drugs. Burke rallied thousands of media and communications professionals to support the cause. Campaigns were created pro bono by hundreds of advertising agencies; media companies donated millions of dollars in broadcast time and print space to carry the campaigns. Under Burke's leadership, the Partnership would grow to become one of the most effective organizations combating substance abuse in the United States.

At a ceremony held in the East Room of the White House on August 9, 2000, President Bill Clinton awarded Burke the Presidential Medal of Freedom in recognition of his outstanding corporate and civic leadership. The Presidential Medal of Freedom is the nation's highest civilian award. It is reserved for individuals the President deems to have made extraordinary contributions to the country. As one of America's most respected corporate leaders of his time, and as an admired leader in the fight against drug abuse, Burke's career came to define modern-day corporate social responsibility, as well as civic responsibility.

In a letter to President Bill Clinton offered in support of Burke's nomination for the Presidential Medal of Freedom, President George H.W. Bush said: "Jim deserves the award not only for his tireless and unselfish work in the fight against drugs, but also for his exemplary business leadership when he was CEO of Johnson & Johnson." 

" Jim Burke believed 100 percent in the Johnson & Johnson Credo, as he exemplified when he took Tylenol off the shelves (in 1982 and 1986)," said Thomas S. Murphy, former chairman and chief executive officer of Capital Cities / ABC. Murphy met Burke at the Harvard Business School; they were roommates for many years, and became lifelong friends. "Jim also was a great believer in America.  To me, he was a wonderful friend."

" Jim Burke's business acumen, leadership skills and warm, gracious, self-effacing personality turned the Partnership for a Drug-Free America into an incredibly effective national organization that influenced the lives of millions of Americans," said Roy Bostock, chairman emeritus of the Partnership. "Jim used his special gifts to help others. He richly deserved the Presidential Medal of Freedom, awarded to him by President Clinton."

Burke and his wife, Didi, have been long-time residents of Princeton, New Jersey.  He is survived by his wife, Didi; his son, James of Princeton; his daughter, Clo Burke of San Antonio, Texas; a sister, Phyllis Burke Davis of Bridgehampton, New York; and four grandchildren.  

For a chronology of Burke's career, click here:

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs